Turkiye Klinikleri Journal of Nursing Sciences

.: REVIEW
Erkek Kontrasepsiyonunda Engeller: Literatür İncelemesi
Barriers in Male Contraception: Literature Review
Gonca BURANa, Hilmiye AKSUb
aHemşirelik Bölümü, Doğum, Kadın Sağlığı ve Hastalıkları Hemşireliği ABD, Bursa Uludağ Üniversitesi Sağlık Bilimleri Fakültesi, Bursa, TÜRKİYE
bDoğum, Kadın Sağlığı ve Hastalıkları Hemşireliği ABD, Aydın Adnan Menderes Üniversitesi Hemşirelik Fakültesi, Aydın, TÜRKİYE
Turkiye Klinikleri J Nurs Sci. 2019;11(4):399-408
doi: 10.5336/nurses.2019-66609
Article Language: TR
Full Text
ÖZET
 Dünya nüfusunun hızlı artışı ve istenmeyen gebelik oranlarının hâlâ yüksek olması, aile planlamasının önemini artırmaktadır. Kontrasepsiyonun çeşitliliğinin artırılması, yöntemlerin olumsuz etkilerinin azaltılmasına ilişkin çalışmalar yıllardır devam etmekte ve yeni yöntemler çiftlerin kullanımına sunulmaktadır. Ancak geliştirilen ve kullanıma sunulan bu yöntemler kadına yönelik olup, aile planlamasındaki büyük sorumluluk kadınlara yüklenmektedir. Bu çalışmada literatür incelemesi yapılarak, erkek kontrasepsiyonunda yıllardır çeşitli çalışmalar sürmesine rağmen neden kullanıma sunulan yöntem olmadığı, erkek kontrasepsiyonundaki engellerin belirlenmesi amaçlanmıştır. Erkek kontrasepsiyonunda çeşitliliğin artırılmasına ilişkin çalışmalar 1970'li yıllarda başlamasına rağmen yıllardır kondom, vazektomi ve geri çekme dışında kullanıma sunulan yeni yöntem yoktur. Geliştirilmeye çalışılan yeni bariyer, hormonal, nonhormonal yöntemlerin bazıları hayvan deneyleri, bazıları da insan deneyleri aşamasındadır. Literatür incelendiğinde, çalışmada erkek kontrasepsiyonundaki engellere ilişkin temel bulgular iki ana başlıkta toplamak mümkündür. Bunlardan birincisi çalışmaların sürdürülmesindeki engeller; maliyetin yüksek olması, çalışmaların istenilen başarıyı sağlayamaması, çalışmaya ilişkin tıbbi girişimlere ilişkin yan etkiler ve kullanım zorluğu nedeni ile gönüllülerin çalışmadan ayrılmasıdır. İkincisi ise erkek kontrasepsiyonunun kullanımını sınırlayan faktörlerdir. Bunlar; cinsiyet ayrımcılığı, dini inançlar, eş onayı, yöntemlerin uygulanış zorluğu, libidoyu etkilemesi, geri dönüşünün olmamasıdır.

Anahtar Kelimeler: Kontraseptif kullanımı; erkek kontrasepsiyonu; erkek kontraseptif ajanlar; erkek kontrasepsiyonunda engeller
ABSTRACT
 The rapid increase in the world population and the high rates of unintented pregnancy are increasing the importance of family planning. Studies on reducing the negative effects of these methods have been continuing for years and new methods are being put into use for couples. However, these methods that are developed and used are directed towards women, and the great responsibility for family planning is imposed on women. In this study, it is aimed to determine the obstacles in male contraception, despite the fact that several studies have been carried out in male contraception for many years. Although studies on increasing the diversity of male contraception started in the 1970s, there has been no new method for years except for condom, vasectomy and withdrawal. Some of the new barrier, hormonal and non-hormonal methods that are tried to be developed are in animal experiments and some are in human experiments stage. When the literature is examined, it is possible to collect the main findings about the obstacles in male contraception in two main titles. The first one is the obstacles in the continuation of the studies; the high cost, the failure of the studies to achieve the desired success, the side effects related to the medical interventions related to the study and the difficulty of use, leaving the volunteers from the study. The second limiting factor is also the use of male contraception. These are gender discrimination, religious beliefs, spousal approval, difficulty of implementation of methods, affecting of libido, lack of return.

Keywords: Contraceptive usage; male contraception; male contraceptive agents; barriers in male contraception
REFERENCES:
  1. Page ST, Amory JK, Bremner WJ. Advances in male contraception. Endocr Rev. 2008;29(4):465-93. [Crossref]  [PubMed]  [PMC] 
  2. United Nations. World Population Prospects: The 2017 Revision. Key Findings and Advance Tables. New York: United Nations; 2017. p.46.
  3. Roth MY, Amory JK. Beyond the condom: frontiers in male contraception. Semin Reprod Med. 2016;34(3):183-90. [Crossref]  [PubMed]  [PMC] 
  4. World Health Organization. Not every pregnancy is welcome. The World Report 2005. Geneva: The World Health Organization; 2005.p.48-51.
  5. Hacettepe Universitesi Nufus Etutleri Enstitusu, T.C. Kalkinma Bakanligi, T.C. Sagglik Bakanligi, Turkiye Bilimsel ve Teknolojik Arastirma Kurumu. Dogurganlik, Aile Planlamasi, Dusukler ve olu Dogumlar. Turkiye Nufus ve Saglik Arastirmasi 2013. Yayin No: NEE-HU.14.01. Ankara: Elma Teknik Basim Matbaacilik Ltd. Sti.; 2013. p.23-104.
  6. Mathew V, Bantwal G. Male contraception. Indian Journal of Endocrinology and Metabolism (IJEM). 2012;16(6):910-7. [Crossref]  [PubMed]  [PMC] 
  7. United Nation, Department of Economic and Social Affairs. Trends in Contraceptive Use Worldwide 2015. New York: United Nations; 2015. p.70.
  8. Shih G, Turok DK, Parker WJ. Vasectomy: the other (better) form of sterilization. Contraception. 2011;83(4):310-5. [Crossref]  [PubMed] 
  9. Pekince GD, Yilmazer M. [Women's opinion about the men's contraception who apply for contraception]. Anadolu Hemsirelik ve Saglik Bilimleri Dergisi. 2012;15(2):69-74.
  10. Kogan P, Wald M. Male contraception history and development. Urol Clin North Am. 2014;41(1):145-61. [Crossref]  [PubMed] 
  11. Campo-Engelstein L, Kaufman S, Parker WM. Where is the pill for the "reproductive man?" Men and Masculinities. 2017:1097184X1770799.
  12. Gabriel ID, Tudorache S, Vladareanu S, Oprescu ND, Muresan MC, Dragusiin RC, et al. Birth Control and Family Planning Using In- trauterine Devices (IUDs). In Family Planning. IntechOpen. 2017; p.257-64. http://dx.doi.org/10.5772/intechopen.72242 [Crossref] 
  13. Wildemeersch D, Andrade A, Goldstuck ND, Hasskamp T, Jackers G. Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience. Int J Womens Health. 2017;9:49-58. [Crossref]  [PubMed]  [PMC] 
  14. Amory JK. Male contraception. Fertil Steril. 2016;106(6):1303-9. [Crossref]  [PubMed]  [PMC] 
  15. Ilani N, Liu PY, Swerdloffi RS, Wang C. Does ethnicity matter in male hormonal contraceptive efficacy? Asian J Androl. 2011;13(4):579-84. [Crossref]  [PubMed]  [PMC] 
  16. Wang C, Festin MPR, Swerdloff RS. Male hormonal contraception: where are we now? Curr Obstet Gynecol Rep. 2016;5(1):38-47. [Crossref]  [PubMed]  [PMC] 
  17. Nieschlag E. Clinical trials in male hormonal contraception. Contraception. 2010;82(5):457-70. [Crossref]  [PubMed] 
  18. Plana O. Male contraception research, new methods, and implications for marginalized populations. American Journal of Men's Health. 2015. https://doi.org/10.1177/1557988315596361 [Crossref]  [PubMed]  [PMC] 
  19. McLachlan RI, McDonald J, Rushford D, Robertson DM, Garrett C, Baker HW. Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception. Contraception. 2000;62(2):73-8. [Crossref] 
  20. Badiei SH, Bahasadri SH. The male contraception supermarket. Shiraz E-Med J. 2009;10(3):138-46.
  21. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, et al. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab. 2003;88(10):4659-67. [Crossref]  [PubMed] 
  22. Anderson RA, Baird DT. Male contraception. Endocr Rev. 2002;23(6):735-62. [Crossref]  [PubMed] 
  23. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990;336(8721):955-9. [Crossref] 
  24. World Health Organization Task Force on Methods for the Regulation of Male Fertility.Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65(4):821-9. [Crossref] 
  25. Cheng CY, Dolores DM. Spermatogenesis. Landes Bioscience. 2011;(1):4281-2. [Crossref]  [PubMed]  [PMC] 
  26. United Nations. Report of the International Conference on Population and Development. Cairo. 1994. https://www.unfpa.org/events/international-conference-population-and-development-icpd
  27. Gu Y, Liang X, Wu W, Liu M, Song S, Cheng L, et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab. 2009;94(6):1910-5. [Crossref]  [PubMed] 
  28. Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, et al. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. J Clin Endocrinol Metab. 1992;75(2):476-83. [Crossref]  [PubMed] 
  29. Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, et al. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab. 2002;87(8):3562-72. [Crossref]  [PubMed] 
  30. Buchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, et al. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab. 1999;84(4):1244-9. [Crossref]  [PubMed] 
  31. Wu FC, Balasubramanian R, Mulders TM, Coelingh-Bennink HJ. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab. 1999;84(1):112-22. [Crossref]  [PubMed] 
  32. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001;54(6):739-50. [Crossref]  [PubMed] 
  33. Hair WM, Kitteridge K, O'Connor DB, Wu FC. A novel male contraceptive pill-patch combination: oral desogestrel and transdermal testosterone in the suppression of spermatogenesis in normal men. J Clin Endocrinol Metab. 2001;86(11):5201-9. [Crossref]  [PubMed] 
  34. Benoff S, Cooper GW, Hurley I, Mandel FS, Rosenfeld DL, Scholl GM, et al. The effect of calcium ion channel blockers on sperm ferti-lization potential. Fertil Steril. 1994;62(3):606-17. http://doi.org/10.1016/ S0015-0282(16)56953-2 [Crossref] 
  35. Lissner EA. Frontiers in non-hormonal male contraception: the next step. Male Contraception Information Project. 2006. www.newmalecontraception.org
  36. Soufir LC. Hormonal, chemical and thermal inhibition of spermatogenesis: contribution of French teams to international data with the aim of developing male contraception in France. Basic Clin Androl. 2017;27:3. [Crossref]  [PubMed]  [PMC] 
  37. Sharpe RM. Environmental/lifestyle effects on spermatogenesis. Philos Trans R Soc Lond B Biol Sci. 2010; 365(1546):1697-712. [Crossref]  [PubMed]  [PMC] 
  38. Wang C, McDonald V, Leung A, Superlano L, Berman N, Hull L, & Swerdloff R. S. Effect of increased scrotal temperature on sperm production in normal men.Fertil Steril. 1997;68(2):334-9. [Crossref] 
  39. Sewak R, Teng B, Learman LA, Hennekens CH. Male contraception: prospects for sound and ultrasound. Med Hypotheses. 2017;107:1-4. [Crossref]  [PubMed] 
  40. Guha SK, Singh G, Srivastava A, Das H, Bhardwaj J, Mathur V, et al. Two-year clinical efficacy trial with dose variations of a vas deferens injectable contraceptive for the male. Contraception. 1998;58(3):165-74. [Crossref] 
  41. Waller D, Bolick D, Lissner E, Premanandan C, Gamerman G. Reversibility of Vasalgel TM male contraceptive in a rabbit model. Basic Clin Androl. 2017;27:8. [Crossref]  [PubMed]  [PMC] 
  42. Colagross-Schouten A, Lemoy MJ, Keesler RI, Lissner E, VandeVoort CA. The contraceptive efficacy of intravas injection of Vasalgel(TM) for adult male rhesus monkeys. Basic Clin Androl. 2017;27:4. [Crossref]  [PubMed]  [PMC] 
  43. Tulsiani DRP, Abou-Haila A. Intra-vas approaches to control male fertility. Austin J Obstet Gynecol. 2016;3(2):1056.
  44. Lu WH, Liang XW, Gu YQ, Wu WX, Bo LW, Zheng TG, et al. A randomized, controlled, multicenter contraceptive efficacy clinical trial of the intravas device, a nonocclusive surgical male sterilization. Asian J Androl. 2014;16(3):432-6. [Crossref]  [PubMed]  [PMC] 
  45. Hardee K, Croce-Galis H, Gay J. Men as Contraceptive Users: Programs, Outcomes and Recommendations. (September). Washington, DC: The Population Council, Inc.; 2016. p.36.
  46. Dorman E, Bishai D. Demand for male contraception. Expert Rev Pharmacoecon Outcomes Res. 2012;12(5):605-13. [Crossref]  [PubMed] 
  47. Meriggiola MC, Cerpolini S, Bremner WJ, Mbizvo MT, Vogelsong KM, Martorana G, et al. Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Hum Reprod. 2006;21(8):2033-40. [Crossref]  [PubMed] 
  48. Mruk DD. New perspectives in non-hormonal male contraception. Trends Endocrinol Metab. 2008;19(2):57-64. [Crossref]  [PubMed] 
  49. Tunckiran MA. [Innovations in male contraception]. Turkiye Klinikleri J Urology-Special Topics. 2017;10(1):68-72.
  50. Mitra S, Kshatriya GK. Failure of male contraception: an insight. Anthropol. 2014;2(2):2-4. [Crossref] 
  51. Thirumalai A, Page ST. Recent developments in male contraception. Drugs. 2019;79(1):11-20. [Crossref]  [PubMed] 
  52. Male Contraception Attitudes: Summary of Surveys and Research, March. 2016. Parsemus Fundation. https://www.parsemus.org/wp-content/uploads/2016/03/Male-Contraception-Attitudes-Surveys-and-Research-7-8-16.pdf
  53. T.C Aile ve Sosyal Politikalar Bakanligi. Kadinin Guclenmesi Strateji Belgesi ve Eylem Plani 2018-2023. Ankara. 2018; 56-169.
  54. Simsek AC, Cakmak D. [Women's health protection policies in force in our country]. The Journal of Gynecology - Obstetrics and Neonatology. 2019;16(1):45-50.
  55. Irawaty DK, Pratomo H. Socio-demographic characteristics of male contraceptive use in Indonesia. Malaysian Journal of Public Health Medicine (MJPHM). 2019;19(1):152-7.
  56. Peterson LM, Campbell MA, Laky ZE. The next frontier for men's contraceptive choice: college men's willingness to pursue male hormonal contraception. Psychology of Men & Masculinity. 2019;20(2):226-37. [Crossref] 
  57. Vera Cruz G, Humeau A, Moore PJ, Mullet E. Identifying determinants of Mozambican men's willingness to use a male contraceptive pill. Eur J Contracept Reprod Health Care. 2019;24(4):266-273. [Crossref]  [PubMed] 
  58. Demir O. [Population policies and evaluation of China, France and Turkey samples]. Social Sciences (NWSASOS). 2016;11(1):41-61. [Crossref] 
  59. Hamza A, Bektas M. [Population policies in Turkey after 2008 and stakeholders analysis]. Ankara Haci Bayram Veli Universitesi Iktisadi ve Idari Bilimler Fakultesi Dergisi. 2018;20(3):483-504.
  60. Cleland J, Harbison S, Shah IH. Unmet need for contraception: issues and challenges. Stud Fam Plan. 2014;45(2):105-22. [Crossref]  [PubMed] 
  61. Kriel Y, Milford C, Cordero J, Suleman F, Beksinska M, Steyn P, et al. Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa. Reprod Health. 2019;16(1):89. [Crossref]  [PubMed]  [PMC] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com